Juvenile idiopathic arthritis (systemic) - canakinumab (terminated appraisal): appendix A - matrix of stakeholders
|
Juvenile idiopathic arthritis (systemic) - canakinumab (terminated appraisal): appendix A - matrix of stakeholders
02 February 2015 (100.48 Kb 29 sec) |
This page was last updated: 02 February 2015